Phio Pharmaceuticals Corp.·4

May 21, 4:13 PM ET

Ferrara Robert L 4

4 · Phio Pharmaceuticals Corp. · Filed May 21, 2025

Insider Transaction Report

Form 4
Period: 2025-05-20
Transactions
  • Purchase

    Common stock, $0.0001 par value

    2025-05-20$1.82/sh+2,500$4,55013,166 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at $1.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the transactions.
  • [F2]Includes shares of common stock underlying unvested restricted stock units.
  • [F3]The number of reported securities has been adjusted to reflect prior reverse stock splits.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES